id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2813274,181d52c4-6e41-4a76-b56b-7978f5593411,2T,MS. TAMI WAHL,401104405,ASSOCIATION OF CANNABIS SPECIALISTS,2022,second_quarter,MED,Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2022-06-09T11:18:37-04:00
2813819,d32eaa18-695d-431e-82a6-fbf33fdf0bfb,Q2,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2022,second_quarter,MED,Issues and legislation related to Alzheimer's disease research,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE",20000,,0,0,2022-07-01T00:16:06-04:00
2813820,04a8d6d7-64c0-407a-a10e-2baf92c43d1a,Q2,"FRANCIS EDWARD & CRONIN, INC.",311314,"PATH DECISION SUPPORT SOFTWARE, LLC",2022,second_quarter,MED,Issues and legislation related to diabetes treatment and diagnosis,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,Veterans Affairs, Dept of (VA)",,,0,0,2022-07-01T00:20:15-04:00
2813878,1adf0cca-79bf-4f29-a066-68ac9c48e2ab,Q2,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2022,second_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2022-07-01T10:05:48-04:00
2813996,f2124a74-56f4-463d-a62d-fe13605202bf,2T,KNIGHT CAPITOL CONSULTANTS,40036301,PERSPECTUM,2022,second_quarter,MED,"Food and Drug Administration regulation of medical devices, monitor development of Medical device user fee legislation","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,1,2022-07-01T14:08:42-04:00
2814068,751e0440-4ead-4f1f-a688-086890f0d117,Q2,"AUBURN HEALTH STRATEGIES, LLC",292697,AMERICAN PROFICIENCY INSTITUTE,2022,second_quarter,MED,Proficiency testing for clinical laboratories,"Health & Human Services, Dept of (HHS),Office of Management & Budget (OMB)",,,0,0,2022-07-01T18:08:07-04:00
2814332,503b1464-6b58-48a4-9430-9b9e8650d321,Q2,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,PPLA,2022,second_quarter,MED,Pharmaceutical Labeling,Food & Drug Administration (FDA),18700,,0,0,2022-07-05T10:58:00-04:00
2814431,a64d7f79-f08d-42e7-a55a-7c8da4819729,Q2,NATURAL RESOURCE RESULTS LLC,321555,SHINE MEDICAL TECHNOLOGIES,2022,second_quarter,MED,Support funding at DOE for fusion technology development.,"Energy, Dept of,SENATE",30000,,0,0,2022-07-05T13:31:54-04:00
2814651,b1599788-aa86-4966-8b2b-21786f53e3fb,Q2,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2022,second_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2022-07-06T05:17:58-04:00
2814702,3b2b1900-f5c7-43b6-993f-be10d969d29a,Q2,"WAYNE STATE UNIVERSITY, DETROIT, MICHIGAN",48805,"WAYNE STATE UNIVERSITY, DETROIT, MICHIGAN",2022,second_quarter,MED,No agencies lobbied in this issue area.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-06T10:42:45-04:00
2814795,4f161aad-4de4-47cf-bbb8-ed4ea3691aba,Q2,UNIVERSITY OF KENTUCKY,400287372,UNIVERSITY OF KENTUCKY,2022,second_quarter,MED,H.R.5585 - ARPA-H Act NIH Funding - FY23 Appropriations Act,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,80850,0,0,2022-07-06T11:55:37-04:00
2815309,0e1df86e-0466-4f48-99e9-5862a65b63b6,Q2,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2022,second_quarter,MED,Labor/HHS/Education Appropriations: Provisions relating to disease research,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-07T16:27:01-04:00
2815572,60f2949c-4423-463d-a5b4-576c74dc43c9,Q2,COVINGTON & BURLING LLP,11195,"SL 2T, LLC (""SMARTLABS"")",2022,second_quarter,MED,"Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including relating to the PREVENT Pandemics Act (S. 3799) and the ARPA-H Act (H.R. 5585).","HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2022-07-08T11:29:36-04:00
2815578,32b77abb-1f9f-4ff7-8556-3c2d77792d22,Q2,"HELIX, INC.",401106164,"HELIX, INC.",2022,second_quarter,MED,"genomic research and testing, COVID-19 testing and research, Lab Developed Tests","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,36520,0,0,2022-07-08T11:32:54-04:00
2815617,bc421a8d-326f-4763-adbc-dc9d08937d71,Q2,CHAMBER HILL STRATEGIES,400645947,SANFORD HEALTH,2022,second_quarter,MED,"H.R. 6000, Cures 2.0 Act.","HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2022-07-08T12:09:43-04:00
2815871,d3dc45d4-88fa-465b-a25a-b73585c0745e,Q2,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,"MOSES WEITZMAN HEALTH SYSTEM, INC.",2022,second_quarter,MED,"Consolidated Appropriations Act, FY 2022, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319 now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, P.L. 117-58 Build Back Better Act, H.R. 5376 FY 2023 House, Senate Department of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Commerce, Justice, Science Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Reauthorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Programs, Postgraduate Psychiatric Fellowships, Medical Assistant Training Programs and other Health Workforce Programs House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Health Centers and Rural Health Clinics House, Senate Infrastructure Bills","Administration for Children & Families (ACF),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Employment & Training Administration,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",10000,,0,0,2022-07-09T05:21:38-04:00
2815878,897e7987-96e8-4860-941c-013e873ac800,Q2,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,"CORNERSTONE CARE, INC.",2022,second_quarter,MED,"FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 537 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills","Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of",,,0,0,2022-07-09T05:52:41-04:00
2815885,34421a6b-5afb-4a78-b951-65bb3a3f5ce6,Q2,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION,2022,second_quarter,MED,"American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills FY 2023 House, Senate Departments of Transportation, Housing and Urban Development, and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills","Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",20000,,0,0,2022-07-09T08:52:42-04:00
2815891,d0de20b8-990d-49ec-9824-3e21df8c9cfc,Q2,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,PIH HEALTH FOUNDATION,2022,second_quarter,MED,"American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",30000,,0,0,2022-07-09T09:25:41-04:00
2815902,b68ea439-dfd7-4f2d-b1ec-9aa95ae89890,Q2,"POWERS PYLES SUTTER & VERVILLE, P.C.",32008,HERBERT J. THOMAS MEMORIAL HOSPITAL ASSOCIATION (FKA THOMAS HEALTH),2022,second_quarter,MED,"Consolidated Appropriations Act, FY 2022, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2022 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2022 House, Senate Department of Agriculture Appropriations Bills FY 2022 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2022 House, Senate Financial Services and General Government Appropriations Bills FY 2022 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills","Administration for Children & Families (ACF),Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of",30000,,0,0,2022-07-09T10:17:25-04:00
2816064,8778baaf-a495-4277-832a-fc42c3c7a676,Q2,BEN BARNES GROUP LP,5415,HUNTSMAN CORPORATION,2022,second_quarter,MED,CMS Medicare,"HOUSE OF REPRESENTATIVES,SENATE",18750,,0,0,2022-07-10T13:43:05-04:00
2816066,5a380b95-6d68-40ec-95d1-b0d6cdfef823,Q2,BEN BARNES GROUP LP,5415,ENVIGO RMS LLC,2022,second_quarter,MED,Medical/Disease Research,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2022-07-10T13:53:13-04:00
2816137,8b8a5e7f-3f6c-4f6f-b48b-cb5aafeefdb1,Q2,PENN AVENUE PARTNERS,400918672,"CLIFFSIDE LABS, LLC",2022,second_quarter,MED,Policy and regulatory matters related to the clinical laboratory industry.,,20000,,0,0,2022-07-10T20:40:02-04:00
2816333,bf095adc-9d1d-4c21-a07e-e7a45cc571c1,Q2,BRAMER GROUP LLC,401103355,"TACTICAL MEDICAL SOLUTIONS, LLC",2022,second_quarter,MED,"Medical Training, FY 2022 NDAA","Army, Dept of (Other),Defense, Dept of (DOD)",8250,,0,0,2022-07-11T11:17:19-04:00
2816516,9946bb78-32af-4862-a17a-3bc444dcc4e3,Q2,PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY,401106232,PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY,2022,second_quarter,MED,Commercial insurance coverage for radiation oncology; Physician fee schedule; HOPPS 2022; RO APM Model; Medicare & Medicaid coverage for radiation oncology; proton therapy,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-11T14:42:53-04:00
2816735,29ab18dd-e9c2-4f47-be95-fc753ae5e0e7,Q2,THE HARRIS FIRM,68376,HOLISTIC INDUSTRIES INC.,2022,second_quarter,MED,Issues pertaining to cannabis CSA scheduling.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-11T21:30:21-04:00
2816742,6babfa1a-617e-4205-8b13-37bed38f656d,2A,NATURAL RESOURCE RESULTS LLC,321555,SHINE MEDICAL TECHNOLOGIES,2022,second_quarter,MED,Support funding at DOE for fusion technology development.,"Energy, Dept of,SENATE",30000,,0,0,2022-07-11T22:15:35-04:00
2816872,902e9a96-bc91-4dfd-a49b-e976fc5fd111,Q2,"EFB ADVOCACY, LLC",401104430,UNITED FOR MEDICAL RESEARCH,2022,second_quarter,MED,Funding Issues Related to the National Institutes of Health,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-12T09:55:45-04:00
2817070,7630260e-0ed1-4144-9cb9-004932c58f97,Q2,THE ROOSEVELT GROUP,400886595,LSU HEALTH SCIENCES FOUNDATION,2022,second_quarter,MED,Provide advocacy and support of research and development efforts inside the DoD and NIH,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-12T12:14:39-04:00
2817093,a997d765-6756-4370-99ab-e168e426398c,Q2,THE ROOSEVELT GROUP,400886595,GUAM REGIONAL MEDICAL CITY,2022,second_quarter,MED,"lobbying on health issues, specifically Medicaid in the US territories","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-12T12:34:40-04:00
2817223,334c0e89-e0d1-4737-b96e-da7622a4b7c8,Q2,BLUEBIRD STRATEGIES,401105447,MYOTONIC,2022,second_quarter,MED,Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-12T13:57:55-04:00
2817227,b27f060d-e96b-4d40-8fad-aa428ca6c523,Q2,BLUEBIRD STRATEGIES,401105447,"MYRIAD GENETICS, INC.",2022,second_quarter,MED,Legislation to regulate clinical labs under CLIA and FDA.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-12T13:59:13-04:00
2817285,a04e3a5c-9bd0-414a-9977-02664cb51228,Q2,BOSE PUBLIC AFFAIRS GROUP,297294,AMERICAN ACADEMY OF ANESTHESIOLOGIST ASSISTANTS,2022,second_quarter,MED,issues related to licensure,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",10000,,0,0,2022-07-12T14:30:18-04:00
2817332,0a5e2709-1e2d-4e0a-80d0-6f53479e5d44,Q2,THE CONSILIO GROUP,400374717,DETECTACHEM,2022,second_quarter,MED,Chemical detection test for COVID-19,"Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office",16500,,0,0,2022-07-12T14:57:34-04:00
2817835,133b4539-4bad-412e-8d31-eeb0bd48a90d,Q2,BROYDRICK & ASSOCIATES,7268,"NORTHSTAR RADIOISOTOPES, LLC",2022,second_quarter,MED,"DOE policies and cooperative agreements expansion legislation, Nuclear medicine CMS Reimbursement, NNSA reorganization. Funding for new cooperative agreements","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-13T10:10:28-04:00
2818051,57caf115-24b0-4801-bddf-169806559ff9,Q2,"CRISPR THERAPEUTICS, INC.",401105184,"CRISPR THERAPEUTICS, INC.",2022,second_quarter,MED,General issues related to FDA approval policies for cell and gene therapies. Policies related to the reauthorization of the Prescription Drug User Fee Act.,"HOUSE OF REPRESENTATIVES,SENATE",,90000,0,0,2022-07-13T12:23:56-04:00
2818082,e9d72a3a-892e-4d6c-b88c-30dd4986e14e,Q2,THE DLM GROUP,313794,"GENESIS HEALTH CARE, INC.",2022,second_quarter,MED,request congressionally directed spending.,,7500,,0,0,2022-07-13T12:53:32-04:00
2818237,b955cf93-002d-4ea5-b22a-725064ae3cb8,Q2,"MAGILL ASSOCIATES, LLC",401103511,THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES,2022,second_quarter,MED,"H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-13T14:31:14-04:00
2818346,65e9a180-e35f-42f2-835d-84c351e136fc,Q2,SQUIRE PATTON BOGGS,30906,"LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.",2022,second_quarter,MED,Funding support for federally qualified health centers; reauthorization of programs,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2022-07-13T15:37:44-04:00
2818582,f97ce2d2-c852-40e9-a2c5-7ca7ee9c96a5,Q2,MICHAEL N. MCCARTY LAW OFFICE PLLC,401104300,AMERICAN MEDICAL TECHNOLOGISTS,2022,second_quarter,MED,"Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2022-07-13T18:56:51-04:00
2818587,c740b98e-51f9-4e91-8bd3-ca9f399e2c1d,Q2,WATKINS & EAGER PLLC,401104403,NATIONAL FRAGILE X FOUNDATION,2022,second_quarter,MED,Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents; possible trail to help individuals with Fragile X.,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2022-07-13T20:09:39-04:00
2818690,ecf1699f-cac4-4313-a7ec-e7dfbec1902f,Q2,"SAM ACTION, INC.",401104337,"SAM ACTION, INC.",2022,second_quarter,MED,"H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE",,10000,0,0,2022-07-14T09:38:25-04:00
2818842,38f9d66d-b039-4b5b-80b6-8d12a44b97d0,Q2,RELX INC.,49511,RELX INC,2022,second_quarter,MED,Issues related to US-UK Cancer Summit and Cancer Moonshot initiative.,"Health & Human Services, Dept of (HHS),Office of Science & Technology Policy (OSTP)",,630000,0,0,2022-07-14T11:49:59-04:00
2818905,b99791aa-f505-494d-a5b7-006633c5613b,Q2,MICHIGAN TECHNOLOGICAL UNIVERSITY,25181,MICHIGAN TECHNOLOGICAL UNIVERSITY,2022,second_quarter,MED,Discussed issues of interest related to higher education for the COVID-19 pandemic.,"HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2022-07-14T12:16:53-04:00
2818909,ab4bb536-3e0d-4747-9228-37371421952f,Q2,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),1466,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),2022,second_quarter,MED,AACC joined with other healthcare groups in providing input to the Senate HELP Committee on the provisions in the Food and Drug Administration Safety and Landmark Advances Act pertaining to the Verifying Accurate Leading-edge IVCT Development Act. AACC met with House and Senate staff and conducted a grassroots campaign urging Congress to keep the VALID Act out of the FDASLA legislation.,"HOUSE OF REPRESENTATIVES,SENATE",,120000,0,0,2022-07-14T12:24:08-04:00
2819110,8aff8cef-cf6f-4a9d-86ba-291a2ab7d556,Q2,"OLD NORTH STRATEGIES, LLC",401106174,"EXELA PHARMA SCIENCES, LLC",2022,second_quarter,MED,bio pharma supply chain reform,"HOUSE OF REPRESENTATIVES,SENATE",78000,,0,0,2022-07-14T14:10:25-04:00
2819188,0fea98bf-04c0-42bd-9756-9c9d60ddac8c,Q2,MANATOS & MANATOS,23634,BARBARA ANN KARMANOS CANCER INSTITUTE,2022,second_quarter,MED,General issues,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-14T14:30:26-04:00
2819248,f0f621c3-7532-4264-a92d-e5f40ff50dcd,Q2,"PARDES BIOSCIENCES, INC.",401106493,"PARDES BIOSCIENCES, INC.",2022,second_quarter,MED,COVID Oral Antivirals,Natl Institutes of Health (NIH),,120000,0,0,2022-07-14T14:54:50-04:00
2819794,9af5225f-3314-47dc-8f4b-6e5edb9d6c74,Q2,"MARSHALL & POPP, LLC",401105121,"BUTTERFLY NETWORK, INC.",2022,second_quarter,MED,"Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act. Issues related to FDA regulation of medical devices, including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2022-07-15T00:38:34-04:00
2819804,d148405c-41ac-4158-8ef6-a0bb0bb4fe93,Q2,IMPACT HEALTH POLICY PARTNERS,401104696,ABBOTT LABORATORIES,2022,second_quarter,MED,"Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-15T07:23:37-04:00
2819807,cb0d2621-9653-42ef-9f3a-46cb4382e7d4,Q2,IMPACT HEALTH POLICY PARTNERS,401104696,CHILDREN'S HOSPITAL COLORADO,2022,second_quarter,MED,"Issues related to pediatric research and children's hospital graduate medical education. H.R.6000, Cures 2.0 Act.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-15T07:25:27-04:00
2819814,fb279c2f-3ae8-437f-9cd8-ca9dad196911,Q2,IMPACT HEALTH POLICY PARTNERS,401104696,HACKENSACK MERIDIAN HEALTH,2022,second_quarter,MED,"Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",40000,,0,0,2022-07-15T07:30:02-04:00
2820258,574af257-7ac0-4b87-98a2-a6b9e09a775a,Q2,"BLUESTONE STRATEGIES, LLC",400658980,VALYRIAN SMOKE LLC,2022,second_quarter,MED,Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-15T11:29:47-04:00
2820331,a2949c52-ef74-44d8-a5f6-483e185e0866,Q2,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2022,second_quarter,MED,Issues related to funding for hospitals,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-15T11:47:47-04:00
2820487,ca65d829-202a-4008-8d87-51e245b35075,Q2,"GOVERNMENT COUNSEL, LLC",401105070,"HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS)",2022,second_quarter,MED,"S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, and H.R. 7667, Food and Drug Amendments of 2022, relating to the establishment of a regulatory framework for laboratory developed tests.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2022-07-15T12:54:30-04:00
2820776,6aa7fa40-f1e6-48b4-9cf2-d890bc07c91f,Q2,TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA,38608,TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA,2022,second_quarter,MED,"Supporting COVID-19 Legislation Telehealth / TREAT Act S4421, CONNECT Act, S2741 Graduate Medical Education Community Health Worker Legislation NIH Funding ARPA-H","HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2022-07-15T15:06:30-04:00
2820991,97be3928-43dc-4821-841c-4232e137d142,Q2,SQUIRE PATTON BOGGS,30906,ALLIANCE FOR BIOSECURITY,2022,second_quarter,MED,Preparedness and response as it relates to Biosecurity.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2022-07-15T16:14:04-04:00
2821152,63570522-bfb1-4695-9614-4ada9e8cadbf,Q2,SQUIRE PATTON BOGGS,30906,"IMPACT JOURNALS, LLC",2022,second_quarter,MED,National Library of Medicine indexing matters.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-15T17:05:18-04:00
2821224,84221e77-8cdb-4a23-9358-ed1accd4a9af,Q2,FORBES-TATE,400976792,AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION,2022,second_quarter,MED,Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-15T17:44:07-04:00
2821343,20494d44-81e3-46ba-9587-b195715889ac,Q2,FORBES-TATE,400976792,"AMGEN USA, INC.",2022,second_quarter,MED,Issues related to Biosimilars; Issues related to drug pricing.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2022-07-15T18:24:27-04:00
2821493,91551bc7-5395-4fa5-a66e-dc76b4055777,Q2,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"ADVANCED MATERIALS AND DEVICES, INC.",2022,second_quarter,MED,Educated key government stakeholders on AMADs products applicable to the military as part of the National Defense Authorization Act and appropriations committees bills.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-15T22:48:00-04:00
2821551,193466ad-99bc-4677-b6eb-e7b47058f3db,Q2,"REPUBLIC CONSULTING, LLC",401016871,IQVIA,2022,second_quarter,MED,Monitored health Data Policy.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2022-07-16T09:05:36-04:00
2821617,d4bcef6c-7bad-4b34-8836-56e4e2aa5f08,Q2,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2022,second_quarter,MED,"H.R.708; S.168 Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2256, S. 834 Resident Physician Shortage Reduction Act of 2021","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2022-07-16T10:46:31-04:00
2821624,396f1e9f-c53f-4881-a279-eb894395f2de,Q2,FORBES-TATE,400976792,CALIFORNIA LIFE SCIENCES ASSOCIATION,2022,second_quarter,MED,Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-16T11:06:38-04:00
2821699,874c1016-5f95-445f-a49d-da96a7197835,Q2,FORBES-TATE,400976792,"COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION",2022,second_quarter,MED,Issues pertaining to government-wide federal regulation of cannabis.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2022-07-16T11:51:17-04:00
2821714,0244b46a-fb76-4978-afe5-2401b2acd06a,Q2,FORBES-TATE,400976792,CSL BEHRING,2022,second_quarter,MED,Issues related to COVID-19 response efforts.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2022-07-16T12:13:52-04:00
2821886,4a92ad6e-320c-4e80-9b01-27fdd5ff2e54,Q2,HAWLEY LLC,401105460,MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO,2022,second_quarter,MED,"Issues related to pathogen testing for COVID 19 and other diseases, including the National Defense Authorization Act for FY2023","Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-16T14:58:58-04:00
2822220,5cb3d169-36ed-43ca-909d-d7fb78489d7b,Q2,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,AMERICAN SOCIETY FOR RADIATION ONCOLOGY,2022,second_quarter,MED,To discuss access to radiation oncology.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES",50000,,0,0,2022-07-16T23:33:09-04:00
2822410,a9358f88-3270-4a75-9f82-53111ba01d17,Q2,"MCHUGH LEMAY ASSOC., LLC",401105253,CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO,2022,second_quarter,MED,Issues related to COVID testing - including H.R. 7900 - National Defense Authorization Act of 2023.,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2022-07-17T11:38:47-04:00
2822632,4da87665-aff3-4fda-8e5c-c4648c69453a,Q2,CAPITOL COUNSEL LLC,313715,"BLUE EARTH DIAGNOSTICS, INC.",2022,second_quarter,MED,To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-17T16:13:31-04:00
2822644,25e0bdcf-0ec2-43b6-80db-906bb50a7018,Q2,CAPITOL COUNSEL LLC,313715,"EMD SERONO, INC.",2022,second_quarter,MED,Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-17T16:26:28-04:00
2822963,31b95f88-9259-47dd-b366-be75e534816d,Q2,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,CHILDREN'S NATIONAL MEDICAL CENTER,2022,second_quarter,MED,"Representation on health-related issues including reimbursement, research, public-health & clinical care","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",50000,,0,0,2022-07-17T22:39:24-04:00
2822973,809e24e5-40a9-43a3-b918-dbd630d5585f,Q2,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,CITY OF HOPE MEDICAL CENTER,2022,second_quarter,MED,"Medicare/Medicaid reimbursement, clinical research","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-17T23:01:41-04:00
2823193,d3ae5a4e-63bc-4718-9aa3-fedb0d1afa02,Q2,THE JACKSON LABORATORY,401104723,THE JACKSON LABORATORY,2022,second_quarter,MED,"Issues related to biomedical research, and animals used in biomedical research. Issues related to the creation of a proposed Advanced Research Project Agency-Health agency.","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2022-07-18T09:39:33-04:00
2823209,2dbd5ca7-858f-404f-ab24-33a839ddb6aa,Q2,EMERGENT STRATEGIES,401104778,ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION,2022,second_quarter,MED,"Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021 Issues related to Small Business Innovation Research Program Medical Device User Fee Amendments IV","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-18T09:48:06-04:00
2823324,35aa37f0-db76-4f17-a30d-dce5fe49759d,Q2,DQB INTERNATIONAL,291834,TEXAS BIOMEDICAL RESEARCH INSTITUTE,2022,second_quarter,MED,"FY 2023 Labor, HHS Appropriations Bill","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-18T10:20:32-04:00
2823429,55a85905-f155-4462-b8de-c5cb8553d4e5,Q2,TIBER CREEK GROUP,20744,JAZZ PHARMACEUTICALS,2022,second_quarter,MED,"Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2022-07-18T10:55:53-04:00
2823601,5cc8a662-6e58-4719-b9a5-6aa1639bf175,Q2,BURRELL INTERNATIONAL GROUP LLC,401103483,AVALO THERAPEUTICS,2022,second_quarter,MED,Medical Countermeasures Development of Therapeutics for COVID-19 and Rare Disease,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-18T11:37:24-04:00
2823655,a7095cba-95d2-44b2-b76c-cd0d56d1b964,Q2,CALIFORNIA LIFE SCIENCES,7758,CALIFORNIA LIFE SCIENCES,2022,second_quarter,MED,Support NIH research funding. Support implementation of 21st Century Cures Act. Support implementation of MCIT rule.,"HOUSE OF REPRESENTATIVES,SENATE",,190000,0,0,2022-07-18T11:49:35-04:00
2823771,808e8bdd-eeb1-42da-813a-571c80e4aa8b,Q2,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2022,second_quarter,MED,Cancer research Oncology product review at the FDA Pediatric research and cancer care Clinical trials Diversity in clinical trials,"HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2022-07-18T12:15:19-04:00
2823854,c88cd747-13a2-425a-afc0-a2391c9983e2,Q2,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",401103161,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",2022,second_quarter,MED,NONE,,,10000,0,0,2022-07-18T12:27:46-04:00
2824099,826aa1b1-2907-4e68-a2a5-d39329a0196d,Q2,DREXEL UNIVERSITY,40032273,DREXEL UNIVERSITY,2022,second_quarter,MED,"Research, education and other matters related to higher ed.","HOUSE OF REPRESENTATIVES,SENATE",,81000,0,0,2022-07-18T12:59:01-04:00
2824101,1dc81afa-c877-46aa-bd37-07482c0172ad,Q2,"TWENTY-FIRST CENTURY GROUP, INC.",38687,NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX),2022,second_quarter,MED,Research and treatment related to suicide prevention for veterans and patients with bipolar depression.,"HOUSE OF REPRESENTATIVES,SENATE",24000,,0,0,2022-07-18T12:59:07-04:00
2824111,0936e4a1-0030-4fa9-a761-1e6db80df79f,Q2,DREXEL UNIVERSITY,40032273,ST. CHRISTOPHER'S HOSPITAL FOR CHILDREN,2022,second_quarter,MED,Children's health and welfare,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-18T13:00:31-04:00
2824117,9bf85c20-037d-4943-8dde-39cf597397a5,Q2,AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS,52105,AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS,2022,second_quarter,MED,"Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act Support legislation aimed at accelerating medical research and patient access to novel therapeutics HR 6000 the ""Cures 2.0 Act""","HOUSE OF REPRESENTATIVES,SENATE",,374911,0,0,2022-07-18T13:01:41-04:00
2824163,1979df22-1a58-42c4-9f86-5a424bfb1565,Q2,STRATEGIES 360,79175,"INNOVA MEDICAL GROUP, INC.",2022,second_quarter,MED,Issues relating to the FDA approval process for medical testing,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2022-07-18T13:10:02-04:00
2824405,7e8cd6a6-2302-4f04-aba7-54195c4437a8,Q2,"TWENTY-FIRST CENTURY GROUP, INC.",38687,GLOBAL ALZHEIMER'S PLATFORM INNOVATIONS PBC,2022,second_quarter,MED,"Issues related to diversity in clinical trials, Alzheimers research, and HR 5585, the ARPA-H Act.","HOUSE OF REPRESENTATIVES,SENATE",24000,,0,0,2022-07-18T13:52:24-04:00
2824575,1eaef260-06c1-4586-82f3-56b28c98bc77,Q2,ALLIANCE FOR AGING RESEARCH,401010854,ALLIANCE FOR AGING RESEARCH,2022,second_quarter,MED,-Establishing a Neuroscience Center of Excellence within the FDA -H.R. 6000 Cures 2.0 Act -FDA clinical trial diversity -Patient-centered outcomes research principles with ARHQ,"Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2022-07-18T14:16:45-04:00
2824605,f6b8c8c9-0a3a-4e8a-b63c-5117e29f0b42,Q2,RICCHETTI INCORPORATED,62778,VAXART INC.,2022,second_quarter,MED,Legislative and regulatory policies regarding oral vaccine development and funding,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2022-07-18T14:19:58-04:00
2824633,b4bf3c99-3a71-4b61-bb67-d1165b3c9509,Q2,DANA-FARBER CANCER INSTITUTE,401106163,DANA-FARBER CANCER INSTITUTE,2022,second_quarter,MED,"Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act","HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE",,78000,0,0,2022-07-18T14:24:02-04:00
2824734,9bdb7201-0789-4f21-9b7d-e1e3fe3d6cf7,Q2,"BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER)",292538,SONIC HEALTHCARE USA,2022,second_quarter,MED,"Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2022-07-18T14:38:56-04:00
2825366,cbe60385-c839-4c6c-bf9c-53e4d7869fdf,Q2,"THE LIVINGSTON GROUP, LLC",49635,INNOVATIVE VACCINE TECHNOLOGIES,2022,second_quarter,MED,"H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2022-07-18T15:51:27-04:00
2825404,732f83d9-d125-4de2-a4c4-0baa4d0526b3,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,DEFENSE HEALTH RESEARCH CONSORTIUM,2022,second_quarter,MED,"HR 8236, FY23 Defense Appropriations Act","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2022-07-18T15:54:27-04:00
2825423,648ce811-86d9-4a96-9234-f4295d0b7cdc,Q2,BIOTECHNOLOGY INNOVATION ORGANIZATION,6245,BIOTECHNOLOGY INNOVATION ORGANIZATION,2022,second_quarter,MED,"Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---Implementation of 21st Century Cures Act of 2016 ---Implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---Reauthorization of PAHPA ---Tropical Disease Priority Review (PRV) Program ---White House National Biodefense Strategy Coronavirus (COVID-19) Pandemic ---H.R.550: Immunization Information Systems ---Implementation of Consolidated Appropriations Act for FY 2021 ---R&D Funding for Medical Countermeasures ---Senate HELP Pandemic Preparedness White Paper Funding for Antimicrobial Resistance (AMR) Programs ---FY 2023 Appropriations ---H.R.3932/S.2076: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) ---H.R.4127: DISARM Act ---Implementation of Consolidated Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2023 Appropriations ---H.R.4521: America COMPETES Act of 2022 ---H.R.5376: Build Back Better Act of 2021 ---S.1260: United States Innovation and Competition Act of 2021 ---Build Back Better Act (Discussion Draft Senate) ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of Consolidated Appropriations Act for FY 2021 ---Implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Reauthorization of PAHPA Funding for National Institutes of Health ---FY 2023 Appropriations ---H.R.623: Gabriella Miller Kids First Research Act 2.0 ---H.R.5585: Advanced Research Projects Agency for Health (ARPA-H) Act Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2023 Appropriations ---Funding for 2022-2023 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of Consolidated Appropriations Act for FY 2021 ---Implementation of Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Security Council (NSC),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,White House Office",,3120000,0,0,2022-07-18T15:55:27-04:00
2825552,9134d966-2c37-40f4-b35a-27e7e30a3a60,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,PANCREATIC CANCER ACTION NETWORK (PANCAN),2022,second_quarter,MED,"cancer research at DoD and NIH HR 8236, FY23 Defense Appropriations Act Peer-Reviewed Pancreatic Cancer Research Program HR 8295, FY23 Labor-HHS-Education Act, NIH research on pancreatic cancer","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2022-07-18T16:10:10-04:00
2825574,e6814fbb-a4e2-415a-b470-717724987ab0,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,FOUNDATION FOR PERIPHERAL NEUROPATHY,2022,second_quarter,MED,"HR 8236 FY23 Defense Appropriations Act, DoD funding for peripheral neuropathy research HR 8295,FY23 Labor-HHS-Education Act, NIH Funding for peripheral neuropathy research","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2022-07-18T16:13:52-04:00
2825584,0c70e158-3970-496e-a26b-7d41fcdfd371,Q2,MARSHFIELD CLINIC HEALTH SYSTEM,57830,MARSHFIELD CLINIC HEALTH SYSTEM,2022,second_quarter,MED,"COVID-19, agricultural occupational health, NIOSH","HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2022-07-18T16:15:47-04:00
2825660,61638a43-5370-4fbe-9f79-b9e372054576,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2022,second_quarter,MED,"Tuberous Sclerosis Complex Research Program HR 8295, FY23 Labor-HHS-Appropriations Act, NIH and CDC research on tuberous sclerosis complex HR 8236, FY23 Defense Appropriations Act","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-18T16:34:47-04:00
2825747,ec1c5579-7649-4a03-86c8-77bb615a562e,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ECRI,2022,second_quarter,MED,"Federal Grant and contracting opportunities related to maternal mortality, patient safety and vaccines.","Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2022-07-18T16:44:19-04:00
2825898,1bfd88be-b75f-476d-a6a3-d2efe6285f26,Q2,"THE PETRIZZO GROUP, INC.",305932,OMEROS CORPORATION,2022,second_quarter,MED,Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2022-07-18T17:12:50-04:00